Radiopharmaceutical therapy (RPT) combined with external beam radiotherapy (EBRT) is emerging as a powerful approach in prostate cancer treatment. Historically rooted in early 89Sr trials, this ...

Journal of Nuclear Medicine January 2026, jnumed.125.270906; DOI: https://doi.org/10.2967/jnumed.125.270906 ...

There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.

Radiopharmaceutical therapy (RPT) offers molecular-targeted treatment strategies and presents an ideal model for advancing ...

Figure][1] Michael Teitell, MD, PhD Dr. Michael Teitell is the director of the UCLA Health Jonsson Comprehensive Cancer ...

Journal of Nuclear Medicine December 2025, jnumed.125.270770; DOI: https://doi.org/10.2967/jnumed.125.270770 ...

The antisense oligonucleotide (ASO) tofersen (Qalsody; Biogen) is the first approved therapy for the treatment of amyotrophic lateral sclerosis (ALS) in adults who have a mutation in the SOD1 gene ...

Journal of Nuclear Medicine September 2025, jnumed.125.270115; DOI: https://doi.org/10.2967/jnumed.125.270115 ...

Journal of Nuclear Medicine August 2025, jnumed.124.268841; DOI: https://doi.org/10.2967/jnumed.124.268841 ...

Journal of Nuclear Medicine July 2025, jnumed.125.269729; DOI: https://doi.org/10.2967/jnumed.125.269729 ...

Journal of Nuclear Medicine June 2025, 66 (supplement 1) 251148; ...